Heteroaryl inhibitors of PDE4
US11767334B2 · kind B2 · utility
1Cited by
8References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2022 |
| Grant date | Sep 26, 2023 |
| Priority date | — |
| Expiry date | Jun 23, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.